| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 7.64e-14 | 38 | 54 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.00e-11 | 227 | 54 | 11 | GO:0051015 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.70e-10 | 118 | 54 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 ABCA3 MYH13 SMARCAL1 SMARCAD1 CHD7 SNRNP200 | 6.74e-09 | 614 | 54 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.03e-08 | 230 | 54 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | actin binding | 5.10e-08 | 479 | 54 | 11 | GO:0003779 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.27e-05 | 441 | 54 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 AP1G1 ACTN4 ACTN1 IQGAP3 | 2.91e-05 | 1099 | 54 | 12 | GO:0008092 |
| GeneOntologyMolecularFunction | very-low-density lipoprotein particle receptor binding | 4.29e-05 | 4 | 54 | 2 | GO:0070326 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.36e-04 | 37 | 54 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.59e-04 | 39 | 54 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 1.99e-04 | 8 | 54 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 4.66e-04 | 12 | 54 | 2 | GO:0008140 | |
| GeneOntologyMolecularFunction | helicase activity | 8.77e-04 | 158 | 54 | 4 | GO:0004386 | |
| GeneOntologyMolecularFunction | CARD domain binding | 9.51e-04 | 17 | 54 | 2 | GO:0050700 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.06e-03 | 775 | 54 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.20e-03 | 172 | 54 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.58e-03 | 85 | 54 | 3 | GO:0017018 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.63e-03 | 86 | 54 | 3 | GO:0004197 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.76e-03 | 839 | 54 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.77e-03 | 840 | 54 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.77e-03 | 840 | 54 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.85e-03 | 656 | 54 | 7 | GO:0008047 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 3.21e-03 | 109 | 54 | 3 | GO:0004722 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 3.81e-03 | 34 | 54 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.92e-03 | 127 | 54 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 5.77e-03 | 42 | 54 | 2 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 5.77e-03 | 42 | 54 | 2 | GO:0004812 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.06e-12 | 15 | 53 | 6 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 3.90e-12 | 18 | 53 | 6 | GO:0033275 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 GRID2IP CDC42BPA SH3GL2 SH3BP1 CASP4 ACTN4 ACTN1 IQGAP3 | 4.75e-08 | 912 | 53 | 14 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.25e-07 | 153 | 53 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle contraction | 7.39e-07 | 400 | 53 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.76e-07 | 127 | 53 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH3 MYH6 MYH7 GRID2IP CDC42BPA SH3GL2 SH3BP1 CASP4 ACTN4 ACTN1 IQGAP3 | 4.96e-06 | 803 | 53 | 11 | GO:0030036 |
| GeneOntologyBiologicalProcess | muscle system process | 9.52e-06 | 547 | 53 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | adult heart development | 1.27e-05 | 18 | 53 | 3 | GO:0007512 | |
| GeneOntologyBiologicalProcess | ATP metabolic process | 4.96e-05 | 257 | 53 | 6 | GO:0046034 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 8.45e-05 | 283 | 53 | 6 | GO:0009205 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 9.67e-05 | 290 | 53 | 6 | GO:0009199 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 9.85e-05 | 291 | 53 | 6 | GO:0009144 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 1.32e-04 | 307 | 53 | 6 | GO:0009141 | |
| GeneOntologyBiologicalProcess | synaptic vesicle uncoating | 1.35e-04 | 7 | 53 | 2 | GO:0016191 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | 1.44e-04 | 449 | 53 | 7 | GO:0051090 | |
| GeneOntologyBiologicalProcess | clathrin coat disassembly | 1.80e-04 | 8 | 53 | 2 | GO:0072318 | |
| GeneOntologyBiologicalProcess | vesicle uncoating | 2.31e-04 | 9 | 53 | 2 | GO:0072319 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor-mediated signaling pathway | 3.18e-04 | 127 | 53 | 4 | GO:0033209 | |
| GeneOntologyBiologicalProcess | skeletal muscle contraction | 3.24e-04 | 52 | 53 | 3 | GO:0003009 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 3.65e-04 | 239 | 53 | 5 | GO:0031032 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 4.70e-04 | 59 | 53 | 3 | GO:0045214 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 4.70e-04 | 59 | 53 | 3 | GO:0055010 | |
| GeneOntologyBiologicalProcess | muscle cell development | 5.27e-04 | 259 | 53 | 5 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 5.46e-04 | 261 | 53 | 5 | GO:0051091 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 7.45e-04 | 69 | 53 | 3 | GO:0050881 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.71e-17 | 16 | 55 | 8 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.41e-15 | 25 | 55 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 4.03e-15 | 28 | 55 | 8 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 2.70e-12 | 59 | 55 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | 2.13e-09 | 273 | 55 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.81e-09 | 290 | 55 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 1.65e-08 | 249 | 55 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 CDC42BPA MYH13 SH3GL1 ACTN4 ACTN1 | 2.54e-08 | 576 | 55 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | actomyosin | 1.40e-05 | 117 | 55 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.16e-05 | 591 | 55 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.81e-04 | 107 | 55 | 4 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.81e-04 | 107 | 55 | 4 | GO:0001725 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 MYH2 CDC42BPA ANXA6 SH3GL1 SH3BP1 LAMA3 ACTN4 ACTN1 IQGAP3 | 2.03e-04 | 976 | 55 | 10 | GO:0070161 |
| GeneOntologyCellularComponent | actin filament bundle | 2.63e-04 | 118 | 55 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | Z disc | 6.70e-04 | 151 | 55 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | intercalated disc | 7.65e-04 | 68 | 55 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | supramolecular fiber | 8.99e-04 | 1179 | 55 | 10 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 9.46e-04 | 1187 | 55 | 10 | GO:0099081 | |
| GeneOntologyCellularComponent | I band | 9.54e-04 | 166 | 55 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | pseudopodium | 1.01e-03 | 18 | 55 | 2 | GO:0031143 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 1.01e-03 | 18 | 55 | 2 | GO:0061702 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.89e-03 | 93 | 55 | 3 | GO:0030864 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.95e-03 | 94 | 55 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | cell cortex | 2.88e-03 | 371 | 55 | 5 | GO:0005938 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 2.91e-03 | 934 | 55 | 8 | GO:0048471 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 4.77e-03 | 129 | 55 | 3 | GO:0030863 | |
| GeneOntologyCellularComponent | nuclear replication fork | 5.47e-03 | 42 | 55 | 2 | GO:0043596 | |
| MousePheno | abnormal neurohypophysis median eminence morphology | 2.39e-05 | 3 | 40 | 2 | MP:0009229 | |
| MousePheno | abnormal hypothalamus physiology | 5.39e-05 | 26 | 40 | 3 | MP:0005645 | |
| Domain | Myosin_N | 1.80e-17 | 15 | 54 | 8 | PF02736 | |
| Domain | Myosin_N | 1.80e-17 | 15 | 54 | 8 | IPR004009 | |
| Domain | Myosin_tail_1 | 1.21e-16 | 18 | 54 | 8 | PF01576 | |
| Domain | Myosin_tail | 1.21e-16 | 18 | 54 | 8 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 2.09e-16 | 19 | 54 | 8 | IPR027401 | |
| Domain | - | 2.09e-16 | 19 | 54 | 8 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 1.07e-15 | 38 | 54 | 9 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.07e-15 | 38 | 54 | 9 | PS51456 | |
| Domain | Myosin_head | 1.07e-15 | 38 | 54 | 9 | PF00063 | |
| Domain | MYSc | 1.07e-15 | 38 | 54 | 9 | SM00242 | |
| Domain | IQ_motif_EF-hand-BS | 8.12e-14 | 90 | 54 | 10 | IPR000048 | |
| Domain | IQ | 1.14e-13 | 93 | 54 | 10 | PS50096 | |
| Domain | IQ | 1.56e-12 | 81 | 54 | 9 | SM00015 | |
| Domain | IQ | 2.63e-11 | 71 | 54 | 8 | PF00612 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 ABCA3 MYO15B MYH13 SMARCAL1 SMARCAD1 CHD7 SNRNP200 | 8.47e-08 | 848 | 54 | 14 | IPR027417 |
| Domain | - | 1.62e-06 | 30 | 54 | 4 | 1.20.1270.60 | |
| Domain | AH/BAR-dom | 1.62e-06 | 30 | 54 | 4 | IPR027267 | |
| Domain | BAR | 1.01e-05 | 15 | 54 | 3 | SM00721 | |
| Domain | BAR | 1.01e-05 | 15 | 54 | 3 | PF03114 | |
| Domain | BAR_dom | 1.25e-05 | 16 | 54 | 3 | IPR004148 | |
| Domain | BAR | 2.14e-05 | 19 | 54 | 3 | PS51021 | |
| Domain | SNF2_N | 1.07e-04 | 32 | 54 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.07e-04 | 32 | 54 | 3 | PF00176 | |
| Domain | EF-hand_Ca_insen | 1.22e-04 | 6 | 54 | 2 | IPR014837 | |
| Domain | EFhand_Ca_insen | 1.22e-04 | 6 | 54 | 2 | PF08726 | |
| Domain | Helicase_C | 2.58e-04 | 107 | 54 | 4 | PF00271 | |
| Domain | HELICc | 2.58e-04 | 107 | 54 | 4 | SM00490 | |
| Domain | Helicase_C | 2.68e-04 | 108 | 54 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.77e-04 | 109 | 54 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.77e-04 | 109 | 54 | 4 | PS51192 | |
| Domain | DEXDc | 2.77e-04 | 109 | 54 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.87e-04 | 110 | 54 | 4 | IPR014001 | |
| Domain | SANT | 4.07e-04 | 50 | 54 | 3 | SM00717 | |
| Domain | SANT/Myb | 4.57e-04 | 52 | 54 | 3 | IPR001005 | |
| Domain | Pept_C14_p20 | 7.30e-04 | 14 | 54 | 2 | IPR001309 | |
| Domain | Caspase-like_dom | 7.30e-04 | 14 | 54 | 2 | IPR029030 | |
| Domain | CASPASE_P20 | 7.30e-04 | 14 | 54 | 2 | PS50208 | |
| Domain | - | 7.30e-04 | 14 | 54 | 2 | 3.40.50.1460 | |
| Domain | Spectrin_alpha_SH3 | 8.41e-04 | 15 | 54 | 2 | IPR013315 | |
| Domain | CH | 8.79e-04 | 65 | 54 | 3 | SM00033 | |
| Domain | CARD | 9.59e-04 | 16 | 54 | 2 | SM00114 | |
| Domain | EF-hand_1 | 9.72e-04 | 152 | 54 | 4 | PF00036 | |
| Domain | CH | 1.09e-03 | 70 | 54 | 3 | PF00307 | |
| Domain | - | 1.14e-03 | 71 | 54 | 3 | 1.10.418.10 | |
| Domain | CH | 1.23e-03 | 73 | 54 | 3 | PS50021 | |
| Domain | CH-domain | 1.33e-03 | 75 | 54 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 2.00e-03 | 23 | 54 | 2 | IPR001589 | |
| Domain | Spectrin | 2.00e-03 | 23 | 54 | 2 | PF00435 | |
| Domain | ACTININ_2 | 2.00e-03 | 23 | 54 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.00e-03 | 23 | 54 | 2 | PS00019 | |
| Domain | - | 2.47e-03 | 93 | 54 | 3 | 1.10.533.10 | |
| Domain | EF_HAND_1 | 2.85e-03 | 204 | 54 | 4 | PS00018 | |
| Domain | DEATH-like_dom | 2.95e-03 | 99 | 54 | 3 | IPR011029 | |
| Domain | CARD | 2.96e-03 | 28 | 54 | 2 | PF00619 | |
| Domain | Spectrin_repeat | 3.17e-03 | 29 | 54 | 2 | IPR002017 | |
| Domain | CARD | 3.62e-03 | 31 | 54 | 2 | IPR001315 | |
| Domain | Spectrin/alpha-actinin | 3.85e-03 | 32 | 54 | 2 | IPR018159 | |
| Domain | SPEC | 3.85e-03 | 32 | 54 | 2 | SM00150 | |
| Domain | CARD | 4.09e-03 | 33 | 54 | 2 | PS50209 | |
| Domain | EF_HAND_2 | 4.44e-03 | 231 | 54 | 4 | PS50222 | |
| Domain | EF_hand_dom | 4.51e-03 | 232 | 54 | 4 | IPR002048 | |
| Domain | MYB_LIKE | 5.40e-03 | 38 | 54 | 2 | PS50090 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.12e-11 | 132 | 46 | 10 | M11355 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 5.50e-11 | 70 | 46 | 8 | M12294 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 6.75e-06 | 38 | 46 | 4 | M39549 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.98e-04 | 35 | 46 | 3 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 2.15e-04 | 36 | 46 | 3 | M18647 | |
| Pubmed | 1.90e-20 | 7 | 56 | 7 | 35210422 | ||
| Pubmed | 1.90e-20 | 7 | 56 | 7 | 16819597 | ||
| Pubmed | 1.32e-17 | 6 | 56 | 6 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.32e-17 | 6 | 56 | 6 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.32e-17 | 6 | 56 | 6 | 10588881 | |
| Pubmed | 3.69e-16 | 8 | 56 | 6 | 3864153 | ||
| Pubmed | 9.01e-15 | 5 | 56 | 5 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 9.01e-15 | 5 | 56 | 5 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 9.01e-15 | 5 | 56 | 5 | 12919077 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.25e-14 | 13 | 56 | 6 | 8404542 | |
| Pubmed | 3.93e-14 | 14 | 56 | 6 | 24938781 | ||
| Pubmed | 3.93e-14 | 14 | 56 | 6 | 27184118 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.89e-13 | 7 | 56 | 5 | 29758057 | |
| Pubmed | 9.67e-13 | 22 | 56 | 6 | 24301466 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 4.13e-12 | 11 | 56 | 5 | 16024798 | |
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 10388558 | ||
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 20357587 | ||
| Pubmed | 6.03e-12 | 4 | 56 | 4 | 1985022 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.42e-11 | 33 | 56 | 6 | 32094117 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 2.67e-11 | 15 | 56 | 5 | 24852826 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 3.88e-11 | 16 | 56 | 5 | 19922871 | |
| Pubmed | 5.49e-11 | 17 | 56 | 5 | 16124007 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 1.18e-10 | 46 | 56 | 6 | 28827394 | |
| Pubmed | 4.20e-10 | 8 | 56 | 4 | 26993635 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 4.20e-10 | 8 | 56 | 4 | 14667415 | |
| Pubmed | 5.02e-10 | 58 | 56 | 6 | 21884692 | ||
| Pubmed | 7.55e-10 | 9 | 56 | 4 | 31960486 | ||
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 1.26e-09 | 10 | 56 | 4 | 2211821 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 1.26e-09 | 10 | 56 | 4 | 8950513 | |
| Pubmed | 1.48e-09 | 31 | 56 | 5 | 21985497 | ||
| Pubmed | 1.97e-09 | 11 | 56 | 4 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.97e-09 | 11 | 56 | 4 | 29168801 | |
| Pubmed | 1.97e-09 | 11 | 56 | 4 | 8136524 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.95e-09 | 3 | 56 | 3 | 26059207 | |
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 3.95e-09 | 3 | 56 | 3 | 1939265 | |
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 3.95e-09 | 3 | 56 | 3 | 1371481 | |
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 3.95e-09 | 3 | 56 | 3 | 1694848 | |
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 3.95e-09 | 3 | 56 | 3 | 1691980 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 21470888 | ||
| Pubmed | 4.26e-09 | 13 | 56 | 4 | 8948582 | ||
| Pubmed | 4.98e-09 | 39 | 56 | 5 | 38690566 | ||
| Pubmed | MYH1 NCOR1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 SACS CCDC150 KMT2A SIK1 ACTN4 ACTN1 | 5.60e-09 | 1442 | 56 | 15 | 35575683 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 5.92e-09 | 647 | 56 | 11 | 26618866 | |
| Pubmed | 5.96e-09 | 14 | 56 | 4 | 33742095 | ||
| Pubmed | 1.08e-08 | 16 | 56 | 4 | 22090424 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.41e-08 | 17 | 56 | 4 | 22351927 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 11023856 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.58e-08 | 4 | 56 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.58e-08 | 4 | 56 | 3 | 18417546 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 3.94e-08 | 5 | 56 | 3 | 30737693 | |
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 3.94e-08 | 5 | 56 | 3 | 2277065 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 6879174 | ||
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 3.94e-08 | 5 | 56 | 3 | 17584907 | |
| Pubmed | 4.31e-08 | 22 | 56 | 4 | 37468485 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 28381556 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 10764144 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 7.88e-08 | 6 | 56 | 3 | 17559643 | |
| Pubmed | Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. | 1.03e-07 | 27 | 56 | 4 | 36899856 | |
| Pubmed | The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. | 1.38e-07 | 7 | 56 | 3 | 26586200 | |
| Pubmed | 1.84e-07 | 31 | 56 | 4 | 30081710 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH3 MYH6 MYH7 MYH8 CDC42BPA MYH13 KMT2A CIBAR2 SIK1 | 1.88e-07 | 910 | 56 | 11 | 36736316 |
| Pubmed | 1.88e-07 | 538 | 56 | 9 | 28524877 | ||
| Pubmed | 2.10e-07 | 32 | 56 | 4 | 33732701 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 36200826 | ||
| Pubmed | 2.20e-07 | 8 | 56 | 3 | 33667029 | ||
| Pubmed | Muscle-specific gene expression during myogenesis in the mouse. | 3.30e-07 | 9 | 56 | 3 | 7787235 | |
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 19506036 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 6.46e-07 | 11 | 56 | 3 | 38303699 | |
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 30962377 | ||
| Pubmed | 6.46e-07 | 11 | 56 | 3 | 26644518 | ||
| Pubmed | The FgfrL1 receptor is required for development of slow muscle fibers. | 6.46e-07 | 11 | 56 | 3 | 25172430 | |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 7.85e-07 | 197 | 56 | 6 | 29872149 | |
| Pubmed | 8.61e-07 | 12 | 56 | 3 | 8424456 | ||
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 8.61e-07 | 12 | 56 | 3 | 28600496 | |
| Pubmed | 9.47e-07 | 653 | 56 | 9 | 22586326 | ||
| Pubmed | 1.12e-06 | 13 | 56 | 3 | 24876128 | ||
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 1.12e-06 | 13 | 56 | 3 | 10694423 | |
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 1.12e-06 | 13 | 56 | 3 | 7797078 | |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 1.31e-06 | 50 | 56 | 4 | 27597886 | |
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 38327785 | ||
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 21071677 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 16494860 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 16944923 | ||
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 29719249 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21526716 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 18480046 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 2.55e-06 | 2 | 56 | 2 | 9585413 | |
| Pubmed | Murine pulmonary myocardium: developmental analysis of cardiac gene expression. | 2.55e-06 | 2 | 56 | 2 | 7919499 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23111184 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 34010028 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 34384224 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 2726733 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23557398 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 16575183 | ||
| Pubmed | Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13. | 2.55e-06 | 2 | 56 | 2 | 2494889 | |
| Pubmed | Human cardiac myosin heavy chain genes and their linkage in the genome. | 2.55e-06 | 2 | 56 | 2 | 3037493 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21778428 | ||
| Pubmed | Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). | 2.55e-06 | 2 | 56 | 2 | 8307559 | |
| Pubmed | Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome. | 2.55e-06 | 2 | 56 | 2 | 8518795 | |
| Interaction | ACTN2 interactions | 3.12e-11 | 171 | 55 | 10 | int:ACTN2 | |
| Interaction | RSPH6A interactions | 3.96e-10 | 34 | 55 | 6 | int:RSPH6A | |
| Interaction | PRKAG2 interactions | 6.47e-10 | 68 | 55 | 7 | int:PRKAG2 | |
| Interaction | ASAH2 interactions | 7.42e-10 | 6 | 55 | 4 | int:ASAH2 | |
| Interaction | TLE3 interactions | MYH1 NCOR1 MYH2 MYH3 MYH4 MYH7 MYH8 NUP107 KMT2A VIRMA CRTC2 | 4.73e-09 | 376 | 55 | 11 | int:TLE3 |
| Interaction | ABTB2 interactions | 1.07e-08 | 101 | 55 | 7 | int:ABTB2 | |
| Interaction | TSPAN33 interactions | 2.28e-08 | 65 | 55 | 6 | int:TSPAN33 | |
| Interaction | CDK3 interactions | 2.50e-08 | 114 | 55 | 7 | int:CDK3 | |
| Interaction | STK3 interactions | 3.08e-08 | 181 | 55 | 8 | int:STK3 | |
| Interaction | TMEM260 interactions | 3.48e-08 | 13 | 55 | 4 | int:TMEM260 | |
| Interaction | SLC39A3 interactions | 3.58e-08 | 70 | 55 | 6 | int:SLC39A3 | |
| Interaction | ZSCAN5A interactions | 5.89e-08 | 38 | 55 | 5 | int:ZSCAN5A | |
| Interaction | STK4 interactions | 2.46e-07 | 159 | 55 | 7 | int:STK4 | |
| Interaction | MYH8 interactions | 2.96e-07 | 52 | 55 | 5 | int:MYH8 | |
| Interaction | TPM1 interactions | 5.42e-07 | 263 | 55 | 8 | int:TPM1 | |
| Interaction | LZTR1 interactions | 5.67e-07 | 111 | 55 | 6 | int:LZTR1 | |
| Interaction | SBDS interactions | 5.92e-07 | 181 | 55 | 7 | int:SBDS | |
| Interaction | FBXO32 interactions | 9.23e-07 | 386 | 55 | 9 | int:FBXO32 | |
| Interaction | LATS1 interactions | 2.71e-06 | 440 | 55 | 9 | int:LATS1 | |
| Interaction | LHPP interactions | 3.07e-06 | 37 | 55 | 4 | int:LHPP | |
| Interaction | SVIL interactions | 3.19e-06 | 233 | 55 | 7 | int:SVIL | |
| Interaction | AURKC interactions | 5.66e-06 | 43 | 55 | 4 | int:AURKC | |
| Interaction | MYH6 interactions | 5.74e-06 | 94 | 55 | 5 | int:MYH6 | |
| Interaction | HSPB8 interactions | 7.26e-06 | 172 | 55 | 6 | int:HSPB8 | |
| Interaction | AGRN interactions | 7.81e-06 | 267 | 55 | 7 | int:AGRN | |
| Interaction | SIK2 interactions | 1.03e-05 | 106 | 55 | 5 | int:SIK2 | |
| Interaction | ACTN4 interactions | 1.21e-05 | 400 | 55 | 8 | int:ACTN4 | |
| Interaction | MYH3 interactions | 1.22e-05 | 52 | 55 | 4 | int:MYH3 | |
| Interaction | MYH2 interactions | 1.32e-05 | 53 | 55 | 4 | int:MYH2 | |
| Interaction | FHDC1 interactions | 1.52e-05 | 18 | 55 | 3 | int:FHDC1 | |
| Interaction | CFAP141 interactions | 1.53e-05 | 55 | 55 | 4 | int:CFAP141 | |
| Interaction | TPM2 interactions | 2.20e-05 | 209 | 55 | 6 | int:TPM2 | |
| Interaction | PTGES3 interactions | 2.29e-05 | 437 | 55 | 8 | int:PTGES3 | |
| Interaction | HIF1A interactions | 2.44e-05 | 441 | 55 | 8 | int:HIF1A | |
| Interaction | MCM2 interactions | MYH1 MYH2 MYH4 MYH6 MYH8 SARS1 KMT2A SIK1 ACTN4 ACTN1 VIRMA SNRNP200 | 2.75e-05 | 1081 | 55 | 12 | int:MCM2 |
| Interaction | HDAC1 interactions | MYH1 NCOR1 MYH2 MYH4 MYH7 MYH8 CDC42BPA NUP107 GON4L KMT2A SMARCAD1 VIRMA | 3.50e-05 | 1108 | 55 | 12 | int:HDAC1 |
| Interaction | MYH4 interactions | 4.70e-05 | 73 | 55 | 4 | int:MYH4 | |
| Interaction | MECOM interactions | 5.13e-05 | 358 | 55 | 7 | int:MECOM | |
| Interaction | RBPJ interactions | 6.53e-05 | 254 | 55 | 6 | int:RBPJ | |
| Interaction | CCDC69 interactions | 7.41e-05 | 30 | 55 | 3 | int:CCDC69 | |
| Interaction | LACTB2 interactions | 7.41e-05 | 82 | 55 | 4 | int:LACTB2 | |
| Interaction | SIN3A interactions | 7.47e-05 | 380 | 55 | 7 | int:SIN3A | |
| Interaction | MAP3K1 interactions | 7.71e-05 | 161 | 55 | 5 | int:MAP3K1 | |
| Interaction | MYL2 interactions | 8.19e-05 | 31 | 55 | 3 | int:MYL2 | |
| Interaction | FKBP6 interactions | 8.93e-05 | 86 | 55 | 4 | int:FKBP6 | |
| Interaction | TAB2 interactions | 9.69e-05 | 169 | 55 | 5 | int:TAB2 | |
| Interaction | SNRK interactions | 1.18e-04 | 35 | 55 | 3 | int:SNRK | |
| Interaction | BCAP31 interactions | 1.21e-04 | 554 | 55 | 8 | int:BCAP31 | |
| Interaction | ZMYND11 interactions | 1.26e-04 | 94 | 55 | 4 | int:ZMYND11 | |
| Interaction | MYH7 interactions | 1.67e-04 | 101 | 55 | 4 | int:MYH7 | |
| Interaction | SIRT7 interactions | 1.68e-04 | 744 | 55 | 9 | int:SIRT7 | |
| Interaction | KIF13A interactions | 1.77e-04 | 40 | 55 | 3 | int:KIF13A | |
| Interaction | ATXN3 interactions | 1.83e-04 | 439 | 55 | 7 | int:ATXN3 | |
| Interaction | HEATR5B interactions | 2.35e-04 | 44 | 55 | 3 | int:HEATR5B | |
| Interaction | LRRC31 interactions | 2.39e-04 | 205 | 55 | 5 | int:LRRC31 | |
| Interaction | TRIM37 interactions | 2.90e-04 | 630 | 55 | 8 | int:TRIM37 | |
| Interaction | SIX1 interactions | 3.24e-04 | 49 | 55 | 3 | int:SIX1 | |
| Interaction | PRR5-ARHGAP8 interactions | 3.25e-04 | 10 | 55 | 2 | int:PRR5-ARHGAP8 | |
| Interaction | MKI67 interactions | 3.51e-04 | 648 | 55 | 8 | int:MKI67 | |
| Interaction | PALLD interactions | 3.54e-04 | 123 | 55 | 4 | int:PALLD | |
| Interaction | EED interactions | NCOR1 INTS14 NUP107 AP1G1 LARS1 ACTN4 SMARCAD1 CHD7 ACTN1 VIRMA SNRNP200 XPO7 | 4.30e-04 | 1445 | 55 | 12 | int:EED |
| Interaction | TNNI1 interactions | 4.32e-04 | 54 | 55 | 3 | int:TNNI1 | |
| Interaction | MYB interactions | 4.76e-04 | 133 | 55 | 4 | int:MYB | |
| Interaction | IGSF8 interactions | 4.83e-04 | 239 | 55 | 5 | int:IGSF8 | |
| Interaction | CFTR interactions | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 MYH13 LAMA3 ACTN4 ACTN1 IQGAP3 | 5.33e-04 | 1480 | 55 | 12 | int:CFTR |
| Interaction | TARS3 interactions | 5.61e-04 | 59 | 55 | 3 | int:TARS3 | |
| Interaction | SACS interactions | 5.61e-04 | 59 | 55 | 3 | int:SACS | |
| Interaction | DNAJA2 interactions | 6.50e-04 | 542 | 55 | 7 | int:DNAJA2 | |
| Interaction | CHST11 interactions | 6.52e-04 | 14 | 55 | 2 | int:CHST11 | |
| Interaction | RNU6ATAC interactions | 6.52e-04 | 14 | 55 | 2 | int:RNU6ATAC | |
| Interaction | NEURL2 interactions | 6.52e-04 | 14 | 55 | 2 | int:NEURL2 | |
| Interaction | ZNF484 interactions | 6.52e-04 | 14 | 55 | 2 | int:ZNF484 | |
| Cytoband | 17p13.1 | 3.54e-07 | 118 | 56 | 5 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 4.15e-06 | 346 | 56 | 6 | chr17p13 | |
| Cytoband | 14q12 | 2.08e-03 | 55 | 56 | 2 | 14q12 | |
| GeneFamily | Myosin heavy chains | 1.39e-18 | 15 | 39 | 8 | 1098 | |
| GeneFamily | N-BAR domain containing | 2.01e-06 | 12 | 39 | 3 | 1289 | |
| GeneFamily | Actinins | 2.71e-05 | 4 | 39 | 2 | 1112 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.02e-04 | 53 | 39 | 3 | 532 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.90e-03 | 30 | 39 | 2 | 959 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 8.82e-08 | 20 | 56 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 1.09e-07 | 21 | 56 | 4 | MM1102 | |
| Coexpression | HALLMARK_MYOGENESIS | 4.33e-06 | 200 | 56 | 6 | M5909 | |
| Coexpression | WANG_NFKB_TARGETS | 1.81e-05 | 24 | 56 | 3 | MM1302 | |
| Coexpression | WANG_NFKB_TARGETS | 1.81e-05 | 24 | 56 | 3 | M2307 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 6.69e-05 | 199 | 56 | 5 | M1466 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP | 6.85e-05 | 200 | 56 | 5 | M4528 | |
| Coexpression | MARTIN_INTERACT_WITH_HDAC | 9.30e-05 | 41 | 56 | 3 | M15154 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.01e-04 | 217 | 56 | 5 | MM1156 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.59e-08 | 77 | 56 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.21e-07 | 125 | 56 | 5 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.05e-06 | 144 | 56 | 5 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 62 | 56 | 4 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-06 | 62 | 56 | 4 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-06 | 147 | 56 | 5 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-06 | 65 | 56 | 4 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-06 | 65 | 56 | 4 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-06 | 157 | 56 | 5 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.66e-06 | 158 | 56 | 5 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-06 | 159 | 56 | 5 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-06 | 160 | 56 | 5 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.37e-06 | 170 | 56 | 5 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-06 | 186 | 56 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.78e-06 | 187 | 56 | 5 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.88e-06 | 188 | 56 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 190 | 56 | 5 | aaf5f1c1ff7b1454f4e5dacfeb48e1c3627e3372 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 190 | 56 | 5 | a20123d5c6cb8c2f0dfd99bbfdb571a73c36234d | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-06 | 192 | 56 | 5 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 192 | 56 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-06 | 192 | 56 | 5 | f51b3fd962263920a6cae783ca7af13f5eb7aaa3 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-06 | 192 | 56 | 5 | 6244541688f85917018a057aa0b3e5972934dfbc | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.30e-06 | 192 | 56 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.84e-06 | 97 | 56 | 4 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.13e-05 | 110 | 56 | 4 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-05 | 129 | 56 | 4 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-05 | 130 | 56 | 4 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-05 | 131 | 56 | 4 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.61e-05 | 148 | 56 | 4 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.33e-05 | 54 | 56 | 3 | 13431c23a110070a11de41773233a8d6583d902c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.33e-05 | 54 | 56 | 3 | cd64ee5c47df5dba0cea954cb115a8de0efb55d1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.02e-05 | 161 | 56 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-05 | 162 | 56 | 4 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-05 | 162 | 56 | 4 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Sema3c_(Entorhinal_cortex)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.37e-05 | 58 | 56 | 3 | 69c0632da1f82800951c11d456a36be9c5abb999 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Sema3c_(Entorhinal_cortex)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.37e-05 | 58 | 56 | 3 | c4d5faa29ee606e5682865624f4b5cffda8fb650 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-05 | 164 | 56 | 4 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.34e-05 | 171 | 56 | 4 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 62 | 56 | 3 | 461d280a1b955033186cfc326f9ace85b4a53c54 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(Neuron.Gad1Gad2.Sst-Nr2f2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 62 | 56 | 3 | 9db88da996b9977f5a89afe505cd55e7b5324bc9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-05 | 173 | 56 | 4 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 174 | 56 | 4 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 174 | 56 | 4 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.21e-05 | 64 | 56 | 3 | bf923a66b17e717b8d3817b9d0e201b82a7e4a88 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.21e-05 | 64 | 56 | 3 | f8f43ad9354c786b418bac54614f96f50e8bea68 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.21e-05 | 64 | 56 | 3 | a3e852600c53b11175eb579e92962fa711f5678b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-05 | 177 | 56 | 4 | d7976eac7e27044f6a859cc0c3398d08576e8c01 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.74e-05 | 180 | 56 | 4 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.25e-05 | 183 | 56 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 185 | 56 | 4 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | Epithelial-C_(AT2)|World / shred on cell class and cell subclass (v4) | 8.78e-05 | 186 | 56 | 4 | b7b1763fc52b4485d843a4a6727055e6c95ebad3 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.78e-05 | 186 | 56 | 4 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-05 | 187 | 56 | 4 | a5318c888b334e8695f38971a7d100b93cdaf04b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-05 | 187 | 56 | 4 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-05 | 187 | 56 | 4 | 64ba0df991eab8b2632751805d758c5f2711f4d7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.15e-05 | 188 | 56 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.15e-05 | 188 | 56 | 4 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.15e-05 | 188 | 56 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 9.15e-05 | 188 | 56 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.15e-05 | 188 | 56 | 4 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.34e-05 | 189 | 56 | 4 | da014519d6eb21bc2dc2ed65eafe638b42a068ed | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.53e-05 | 190 | 56 | 4 | a51405f8466fc6d4087873137472619b2e84c1da | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.53e-05 | 190 | 56 | 4 | 059beca1c92181b8ba4dcd6fc71ff7530d83d0de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.73e-05 | 191 | 56 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.73e-05 | 191 | 56 | 4 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.73e-05 | 191 | 56 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.73e-05 | 191 | 56 | 4 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | droplet-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.73e-05 | 191 | 56 | 4 | caed913e7ede9f8ae3af273d1ecf375de6c5e813 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.92e-05 | 192 | 56 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 9.92e-05 | 192 | 56 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.92e-05 | 192 | 56 | 4 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.92e-05 | 192 | 56 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 193 | 56 | 4 | ba484fa1f290a92ae02475a4c468b4ac840c133e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 193 | 56 | 4 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-04 | 193 | 56 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | cellseq2-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 194 | 56 | 4 | df835578d86a49ae5af5632152fbab9548c0a448 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 194 | 56 | 4 | 4e93bd903cddfd0c8f220b6a35b449895de4119b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 194 | 56 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | cellseq2-Epithelial-Epithelial_Alveolar|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 194 | 56 | 4 | 0715f2d55f4a6d2edda1b3dc52f12d25ce59eb10 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Alveolar-AT2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 194 | 56 | 4 | a4f7cd507eba40985d82635bbae28c7f5703f883 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 194 | 56 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.03e-04 | 194 | 56 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 194 | 56 | 4 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | (7)_Epithelial-J_(AT1-AT2_progenitors)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.05e-04 | 195 | 56 | 4 | 70e6b58c502a2abeb4e36bed179020c675468bd4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | 3e24570def013d5b0b1ef1d7a5ced7dfd922590b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 195 | 56 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | 6617abca0009ad3d8731f515f91ab275f9ea4c40 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.05e-04 | 195 | 56 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 195 | 56 | 4 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 195 | 56 | 4 | ce1ba5911e8a6ddb07434acc37147c38e94245ff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 195 | 56 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 196 | 56 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 196 | 56 | 4 | 0a34a0009f479384f1994c6f977f942699a132c8 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-04 | 197 | 56 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 197 | 56 | 4 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-04 | 197 | 56 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.12e-04 | 198 | 56 | 4 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 199 | 56 | 4 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| Computational | Genes in the cancer module 202. | 1.16e-04 | 28 | 37 | 3 | MODULE_202 | |
| Drug | fast white | 7.55e-14 | 42 | 55 | 8 | CID000024008 | |
| Drug | formycin triphosphate | 4.01e-13 | 51 | 55 | 8 | CID000122274 | |
| Drug | purealin | 1.19e-12 | 58 | 55 | 8 | CID006419303 | |
| Drug | blebbistatin | 8.82e-12 | 116 | 55 | 9 | CID003476986 | |
| Drug | SM-2 | 3.44e-11 | 87 | 55 | 8 | CID000486033 | |
| Drug | S-(-)-Etomoxir | 1.07e-10 | 100 | 55 | 8 | CID000060765 | |
| Drug | B0683 | 3.80e-10 | 117 | 55 | 8 | CID006398969 | |
| Drug | NSC339663 | 4.03e-10 | 250 | 55 | 10 | CID000003892 | |
| Drug | oxovanadium | 4.65e-10 | 120 | 55 | 8 | CID000024411 | |
| Drug | 2bq7 | 5.67e-10 | 123 | 55 | 8 | CID006540267 | |
| Drug | AC1LADJ6 | 8.83e-10 | 130 | 55 | 8 | CID000486032 | |
| Drug | 4-chloroaniline | 1.27e-09 | 202 | 55 | 9 | CID000007812 | |
| Drug | AC1NRBPQ | 1.34e-09 | 137 | 55 | 8 | CID005288569 | |
| Drug | clenbuterol | 1.78e-09 | 142 | 55 | 8 | CID000002783 | |
| Drug | candesartan cilexetil | 2.11e-09 | 145 | 55 | 8 | CID000002540 | |
| Drug | AC1N9ZZC | 2.61e-09 | 149 | 55 | 8 | CID004369374 | |
| Drug | carvedilol | 4.82e-09 | 161 | 55 | 8 | CID000002585 | |
| Drug | creatine | 2.00e-08 | 193 | 55 | 8 | CID000000586 | |
| Drug | trifluoperazine | 7.66e-08 | 324 | 55 | 9 | CID000005566 | |
| Drug | NSC611747 | 1.55e-07 | 352 | 55 | 9 | CID000002534 | |
| Drug | MgCl2 | 1.62e-07 | 354 | 55 | 9 | CID000024584 | |
| Drug | eye gene | 2.31e-07 | 369 | 55 | 9 | CID000004782 | |
| Drug | pyrophosphate | 3.83e-07 | 654 | 55 | 11 | CID000001023 | |
| Drug | D-triiodothyronine | 5.46e-07 | 409 | 55 | 9 | CID000000861 | |
| Drug | AC1L1IZ2 | 6.51e-07 | 304 | 55 | 8 | CID000004795 | |
| Drug | NSC107658 | 6.84e-07 | 306 | 55 | 8 | CID000002919 | |
| Drug | NSC9700 | 1.08e-06 | 578 | 55 | 10 | CID000005408 | |
| Drug | NSC226080 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH8 CDC42BPA MYH13 ACTN4 CRTC2 | 2.20e-06 | 782 | 55 | 11 | CID000005040 |
| Drug | 4-epidoxorubicin | 2.37e-06 | 788 | 55 | 11 | CID000001690 | |
| Drug | verapamil | 2.43e-06 | 490 | 55 | 9 | CID000002520 | |
| Drug | nifedipine | 6.55e-06 | 415 | 55 | 8 | CID000004485 | |
| Drug | K-Cl | 7.92e-06 | 567 | 55 | 9 | CID000004873 | |
| Drug | LY294002 | 1.06e-05 | 748 | 55 | 10 | CID000003973 | |
| Drug | Spermine | 1.63e-05 | 63 | 55 | 4 | ctd:D013096 | |
| Drug | nocodazole | 1.80e-05 | 477 | 55 | 8 | CID000004122 | |
| Drug | wartmannin | 2.13e-05 | 811 | 55 | 10 | CID000005691 | |
| Drug | N-ethylmaleimide | 2.94e-05 | 511 | 55 | 8 | CID000004362 | |
| Drug | isoproterenol | 2.94e-05 | 669 | 55 | 9 | CID000003779 | |
| Drug | Prampine [inn:ban] | 3.43e-05 | 4 | 55 | 2 | CID003083997 | |
| Drug | carbachol | 3.66e-05 | 688 | 55 | 9 | CID000002551 | |
| Drug | sodium dodecyl sulfate | 6.97e-05 | 91 | 55 | 4 | CID000008778 | |
| Drug | GC 1 compound | 8.54e-05 | 6 | 55 | 2 | ctd:C413355 | |
| Drug | monomethyl phthalate | 8.59e-05 | 957 | 55 | 10 | ctd:C517284 | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 7269_DN | |
| Drug | Foliosidine [2520-38-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 55 | 5 | 6057_UP | |
| Drug | AC1OAH4V | 1.22e-04 | 105 | 55 | 4 | CID006857726 | |
| Drug | 1-(3-pyridyl)-1-butanone | 1.43e-04 | 42 | 55 | 3 | CID000459502 | |
| Drug | quinaprilat | 1.54e-04 | 43 | 55 | 3 | CID000107994 | |
| Drug | 2-methylbutylamine | 1.65e-04 | 44 | 55 | 3 | CID000007283 | |
| Drug | NpCaM | 2.14e-04 | 48 | 55 | 3 | CID000122259 | |
| Drug | AC1NSUIJ | 2.55e-04 | 10 | 55 | 2 | CID005316686 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 3.28e-21 | 10 | 54 | 8 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.60e-20 | 12 | 54 | 8 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.60e-20 | 12 | 54 | 8 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 9.34e-20 | 13 | 54 | 8 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.66e-19 | 15 | 54 | 8 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.61e-14 | 48 | 54 | 8 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 7.12e-13 | 71 | 54 | 8 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.92e-12 | 80 | 54 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.43e-05 | 80 | 54 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Caveolinopathy | 1.97e-05 | 4 | 54 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 1.97e-05 | 4 | 54 | 2 | 192600 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 1.97e-05 | 4 | 54 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 1.97e-05 | 4 | 54 | 2 | cv:C3495498 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 3.28e-05 | 5 | 54 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 6.86e-05 | 7 | 54 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 6.86e-05 | 7 | 54 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Dilated | 9.45e-05 | 48 | 54 | 3 | C0007193 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.07e-04 | 50 | 54 | 3 | C1449563 | |
| Disease | Distal arthrogryposis | 1.17e-04 | 9 | 54 | 2 | cv:C0265213 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.17e-04 | 9 | 54 | 2 | C0949658 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 1.47e-04 | 10 | 54 | 2 | cv:C5675009 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 4.39e-04 | 17 | 54 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 7.42e-04 | 22 | 54 | 2 | cv:C0949658 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 9.60e-04 | 25 | 54 | 2 | C4551472 | |
| Disease | Limb-girdle muscular dystrophy | 1.04e-03 | 26 | 54 | 2 | cv:C0686353 | |
| Disease | neuroblastoma | 1.27e-03 | 116 | 54 | 3 | EFO_0000621 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.38e-03 | 30 | 54 | 2 | C1868672 | |
| Disease | Primary familial dilated cardiomyopathy | 1.38e-03 | 30 | 54 | 2 | cv:C0340427 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.57e-03 | 125 | 54 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.57e-03 | 125 | 54 | 3 | C1879321 | |
| Disease | Heart Failure, Diastolic | 1.67e-03 | 33 | 54 | 2 | C1135196 | |
| Disease | Primary dilated cardiomyopathy | 1.78e-03 | 34 | 54 | 2 | cv:C0007193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVGKILDAIDDFGLR | 321 | P54793 | |
| DLERDLLDFRAKMQG | 211 | Q6ZTR7 | |
| EEDFRDGLKLMLLLE | 56 | P12814 | |
| DFDITGMKELLEGLD | 156 | P49662 | |
| LSEGMKEEGLFRLAA | 301 | Q9Y3L3 | |
| EDFRDGLKLMLLLEV | 76 | O43707 | |
| ADLLGDRIAIMAKGE | 726 | Q99758 | |
| EDLLRKGAYGALMDE | 1461 | Q9P2D1 | |
| LRFELEDEGKAMLAS | 806 | Q8NB25 | |
| RGELSGDFEKLMLAV | 231 | P08133 | |
| QKFLILGDIDGLMDE | 516 | P57740 | |
| KAGLLGLLEEMRDER | 766 | P12883 | |
| DKRIGYLGAMLLLDE | 81 | O43747 | |
| DGNGLISKDEFIRML | 866 | Q9NRD9 | |
| GDRFISLNIEDGKLM | 2641 | Q16787 | |
| LLVRGKGEMEGEALL | 16 | Q8NA97 | |
| AEGLSEMFRLLVEGK | 526 | Q4ZG55 | |
| MRNAVDEFLLLLDKG | 391 | Q9UDY8 | |
| ERQLRMLEDLGFKDL | 146 | Q9BYM8 | |
| VFFKAGLLGLLEEMR | 766 | P13535 | |
| GLLGLLEEMRDEKLA | 771 | P13535 | |
| GFLVKMSGDLLELAL | 121 | Q8NBP7 | |
| FKAGLLGLLEEMRDD | 771 | Q9UKX2 | |
| AGLLGLLEEMRDEKL | 771 | P12882 | |
| DALLKLRQERGMGED | 486 | Q86VI3 | |
| FKGEGLRMLISRDLD | 1841 | P78509 | |
| MKDLLGGLEVDLDSL | 1291 | Q96JP2 | |
| MALRLVADFDLGKDV | 1 | A4D1B5 | |
| GLLFGMLDRETDRKL | 1151 | Q9P2D3 | |
| LDGLQREAMEELGKA | 1146 | A4D2P6 | |
| REAMEELGKALAFFG | 1151 | A4D2P6 | |
| LRDDLIMLDFGEKRG | 46 | Q8NCX0 | |
| AGLELGLGLEDELRM | 646 | Q53ET0 | |
| AFGFLDLLKGVADML | 446 | Q96SY0 | |
| MFLAKALLEGADRGL | 1 | Q96L46 | |
| DLKLDDMLDRTLEDG | 266 | Q3T8J9 | |
| LQARMGDLKGVLDDL | 461 | Q9Y2G2 | |
| RKELVDMLGDDGVFL | 436 | Q6GMR7 | |
| LGLDSNREKDMGLFE | 2881 | Q03164 | |
| LLDKLRSDGAELLMF | 2726 | Q9NZJ4 | |
| DLLDARLGMKDAAEL | 6 | Q5XKR4 | |
| MVLDLDLFRVDKGGD | 1 | P49591 | |
| DMDLILDSGKFRVLG | 846 | Q9H4L7 | |
| IDKFSADGMRLALAD | 731 | Q9P2J5 | |
| LGLEDIIRKALMGSF | 2261 | O75376 | |
| FAIAKGGRLLLADDM | 446 | Q9NZC9 | |
| LLDGNMDIKLADFGF | 156 | A0A0B4J2F2 | |
| LLDGNMDIKLADFGF | 156 | P57059 | |
| AGLLGTLEEMRDEKL | 771 | Q9Y623 | |
| FKAGLLGTLEEMRDD | 766 | P11055 | |
| FFKAGLLGLLEEMRD | 766 | P13533 | |
| RLADFGSCLKLMEDG | 216 | Q5VT25 | |
| LELMAGGDLKSFLRE | 1196 | Q9UM73 | |
| GDALLDAGESMKRLA | 111 | Q99961 | |
| ALLAEAMLKFGRELG | 91 | Q99962 | |
| AGLLGLLEEMRDEKL | 771 | Q9UKX3 | |
| MCLEKDTLGLFLREG | 741 | O75643 | |
| ALGRLLMVDLGEDED | 671 | Q9UIA9 | |
| MLTELLRGGSFEFKD | 1016 | Q69YN4 |